Other

Actavis to spend $66 billion on Allergan

Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.

Nov 17, 2014
popularity 0 comments 0

What's the current role of liver biopsy in children?

While noninvasive alternatives are increasingly available, liver biopsy still provides essential information in some children with liver disease, according to a new position paper in the Journal of Pediatric Gastroenterology ...

Nov 14, 2014
popularity 0 comments 0